Mark Garcia, MD
Vascular & Interventional Radiology · Wilmington, DENPI 1942260088
Payments from drug & device makers
Across 270 payments — averaging $1794.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$250K
- Vesper Medical$120K
- EKOS Corporation$49K
- Merit Medical Systems Inc$42K
- Cagent Vascular Inc$10K
- Abbott$4K
- plus $11K from 23 others
What the payments were for
- Royalty or licence$29,9806%
- Consulting fees$186,08038%
- Speaking & faculty fees$4,4501%
- Travel & lodging$9060%
- Food & beverage$6,2581%
- Ownership interest$7,6602%
- Other$249,10351%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 6 | $249,576 |
| Vesper Medical | 47 | $120,000 |
| EKOS Corporation | 3 | $49,224 |
| Merit Medical Systems Inc | 29 | $41,520 |
| Cagent Vascular Inc | 8 | $9,723 |
| Abbott | 12 | $3,728 |
| Johnson & Johnson | 11 | $3,599 |
| Boston Scientific | 53 | $1,901 |
| Philips North America LLC | 6 | $1,350 |
| Endologix LLC | 10 | $1,166 |
| Bard Peripheral Vascular, Inc. | 30 | $1,013 |
| Angiodynamics, Inc. | 6 | $258 |
| Cardiovascular Systems Inc. | 6 | $201 |
| Siemens Medical Solutions USA, Inc. | 2 | $178 |
| Stryker | 1 | $141 |
| Nevro Corp. | 6 | $128 |
| Penumbra, Inc. | 2 | $112 |
| Cook Medical LLC | 4 | $99 |
| E.r. Squibb & Sons, L.L.C. | 6 | $96 |
| Avinger Inc. | 4 | $90 |
| Cashflow Solutions, LLC | 2 | $85 |
| Terumo Medical Corporation | 4 | $73 |
| Reflow Medical Inc | 5 | $60 |
| Tactile Systems Technology Inc | 2 | $34 |
| Teleflex LLC | 1 | $22 |
| Resmed Corp | 1 | $17 |
| Intact Vascular, Inc. | 1 | $16 |
| Cardinal Health 200 LLC | 1 | $16 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUO Venous Stent System$90,000
- EKOSONIC$49,200
- Vesper Duo Venous Stent System$30,000
- Revolution Cath Securemnt Dev$24,297
- Revolution Catheter Securement Device$13,154
- Serrantor$9,200
- Perclose ProGlide suture mediated closure system$3,500
- XARELTO$3,450
- (9520) IGT Devices Undivided$1,000
- ENDOCROSS Device$906
- Torus Stent Graft System$906
- Spectranetics Undiv$300
- Serranator$266
- Crosser iQ$263
- ANGIOJET$182
- IN.PACT Admiral$164
- HawkOne$160
- GENERAL - THERAPIES$158
- GENERAL METALLIC STENTS$150
- AUGMENT INJECTABLE$141
How this compares
Too few vascular & interventional radiology providers in Delawareto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 86 | $103,757 |
| EliquisApixaban | 41 | $51,944 |
| ClopidogrelClopidogrel Bisulfate | 52 | $666 |
| Cilostazol | 11 | $547 |
| Triamcinolone Acetonide | 32 | $266 |
| Methylprednisolone | 38 | $219 |
| Prednisone | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $3,599 | $103,75786 claims |
| PfizerEliquis | $12 | $51,94441 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few vascular & interventional radiology providers in Delawareon file to place this against a meaningful peer group, so we don't.
Other vascular & interventional radiology in Wilmington
- Edel MendozaWilmington$51K
- Daniel LeungNewark$335K
- Christopher GrilliNewark$143K
- Assaf GraifNewark$83K
- Demetrios AgriantonisNewark$12K
- Henry SzetoNewark$10K
- Niloy DasguptaDover$8K
- Uchenna NwosuNewark$8K
- David XuDover$7K
- Helen PaikNewark$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.